FDA Modifies Mifepristone REMS Program, Establishes Certific

On January 3, 2023, FDA released an updated Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. The updated REMS follows a December 2021 FDA announcement that it would...

Related Keywords

District Of Columbia , United States , , Danco Laboratories Or Genbiopro Inc , Society Of Maternal , Practice Group , Mifepristone Program , American College Of Obstetricians , Risk Evaluation , Mitigation Strategy , Mifepristone Tablets , Mifepristone Tablet , Prescriber Agreement Form , Patient Agreement Form , New Modifications , Information Page , Danco Laboratories , Prescriber Agreement Forms , Pharmacy Agreement Form , Pharmacy Agreement , Prescriber Agreement , American College , Maternal Fetal Medicine , Janet Woodstock ,